The relationship between 5-fluorouracil sensitivity and single nucleotide polymorphisms of the orotate phosphoribosyl transferase gene in colorectal cancer

Oncology Reports

Volumn 15, Issue 1, 2006, Pages 161-165

  Kitajima, Masayuki ^a   Takita, Naohito ^a   Hata, Masaki ^a   Maeda, Tsutomu ^a   Sakamoto, Kazuhiro ^a   Kamano, Toshiki ^a   Ochiai, Takumi ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Metropolitan Health and Medical Treatment Corporation Ookubo Hospital   (Japan)

Author keywords

5 fluorouracil; Orotate phosphoribosyl transferase; Single nucleotide polymorphism

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; OROTATE PHOSPHORIBOSYLTRANSFERASE;

AGED; ARTICLE; COLORECTAL TUMOR; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; OROTATE PHOSPHORIBOSYLTRANSFERASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33644875441     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.1.161     Document Type: Article

References (16)

1. Ochiai T, Sugitani M, Nishimira K, Noguchi H, Watanabe T, Sengoku H, Kihara A and Okano M: Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyridine dehydrogenase (DPD) in colorectal cancer. Jpn J Cancer Chemother 28: 661-667, 2001.
2. The International SNP Map Working Group: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphism. Nature 409: 928-933, 2001.
3. Lyamichev V and Neri B: Invader assay for SNP genotyping. Methods Mol Biol 212: 229-240, 2003.
4. Fors L, Lieder KW, Vavra SH, et al: Large-scale SNP scoring from unamplified genomic DNA. Pharmacogenomics 1: 219-229, 2000.
5. Nagano M, Yamashita S, Hirano K, et al: Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by invader assay. J Lipid Res 43: 1011-1018, 2002. (Pubitemid 34760871)
6. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987. (Pubitemid 17027905)
7. Kobayashi H, Tanisaka K and Doi O: An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol 11: 449-455, 1997. (Pubitemid 27364274)
8. Kobayashi H, Higashiyama M, Minamigawa K, et al: Examination of in vitro chemosensitivity test using collagen droplet culture method with colorimetric endpoint quantification. Jpn J Cancer Res 92: 203-210, 2001. (Pubitemid 32241776)
9. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL and Miller LL: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914, 2000.
10. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts SR: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30, 2004. (Pubitemid 41095110)
11. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I and De Gramont A: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351, 2004. (Pubitemid 38702845)
12. Glazer RI and Legraverend M: The effect of 5-fluorouridine 5′-triphosphate on RNA transcribe in isolated nuclei in vitro. Mol Pharmacol 17: 279-282, 1979.
13. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L and Danenberg PV: Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 44: 4144-4150, 1984. (Pubitemid 14041649)
14. Hashizume T, Imaoka S, Mise M, et al: Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300: 298-304, 2002. (Pubitemid 34028540)
15. Meyer UA: Pharmacogenetics and adverse drug reactions. Lancet 356: 1667-1671, 2000.
16. Abecasis GR, Noguchi E, Heizmann A, et al : Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 68: 191-197, 2001. (Pubitemid 32048373)